Hypercalcaemia due to thyrotoxicosis.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D013956:Antithyroid Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology*; D006980:Hyperthyroidism / Q000150:complications*; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D001262:Atenolol